How has been the historical performance of Rossari Biotech?

Oct 16 2025 10:41 PM IST
share
Share Via
Rossari Biotech has shown consistent growth from March 2020 to March 2025, with net sales increasing from INR 600.09 crore to INR 2,080.29 crore, and profit after tax rising from INR 65.47 crore to INR 135.40 crore. Key financial metrics, including operating profit and earnings per share, have also improved significantly during this period.
Answer:
The historical performance of Rossari Biotech shows a consistent growth trend across various financial metrics from March 2020 to March 2025.

Breakdown:
Rossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025, reflecting a robust growth trajectory. The total operating income followed a similar upward trend, reaching INR 2,080.29 crore in March 2025, up from INR 600.09 crore in March 2020. The company's operating profit (PBDIT) also saw a steady rise, climbing from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025. Profit before tax increased from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, while profit after tax rose from INR 65.47 crore to INR 135.40 crore over the same period. The earnings per share (EPS) improved from INR 12.86 in March 2020 to INR 24.64 in March 2025, indicating enhanced shareholder value. On the balance sheet, total assets grew from INR 471.46 crore in March 2020 to INR 1,885.67 crore in March 2025, alongside total liabilities increasing from INR 471.46 crore to INR 1,885.67 crore. Cash flow from operating activities improved significantly, reaching INR 137 crore in March 2025, compared to INR 56 crore in March 2020, while the closing cash and cash equivalents rose from INR 29 crore to INR 44 crore in the same timeframe. Overall, Rossari Biotech has demonstrated strong financial performance and growth over the past five years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News